Abstract:Rare diseases are usually chronically debilitating or even life-threatening with diagnostic and therapeutic challenges in current clinical practice. It has been estimated that 80% of rare diseases are genetic in origin, and thus genome sequencing-based diagnosis offers a promising alternative for rare-disease management. In this study, 79 individuals from 16 independent families were performed for whole-genome sequencing (WGS) in an effort to identify the causative mutations for 16 distinct rare diseases that are largely clinically intractable. Comprehensive analysis of variations, including simple nucleotide variants (SNVs), copy-number variations (CNVs), and structural variations (SVs), was implemented using the WGS data. A flexible analysis pipeline that allowed a certain degree of misclassification of disease status was developed to facilitate the identification of causative variants. As a result, disease-causing variants were identified in 10 of the 16 investigated diseases, yielding a diagnostic rate of 62.5%. Additionally, new potentially pathogenic variants were discovered for two disorders, including IGF2/INS-IGF2 in mitochondrial disease and FBN3 in Klippel–Trenaunay–Weber syndrome. Our WGS analysis not only detected a CNV associated with 3p deletion syndrome but also captured a simple sequence repeat (SSR) variation associated with Machado–Joseph disease. To our knowledge, this is the first time the clinical WGS analysis of short-read sequences has been used successfully to identify a causative SSR variation that perfectly segregates with a repeat expansion disorder. After the WGS analysis, we confirmed the initial diagnosis for three of 10 established disorders and modified or corrected the initial diagnosis for the remaining seven disorders. In summary, clinical WGS is a powerful tool for the diagnosis of rare diseases, and its diagnostic clarity at molecular levels offers important benefits for the participating families.

Integration of transcriptomics and long-read genomics prioritizes structural variants in rare disease

Mapping structural variants to rare disease genes using long-read whole genome sequencing and trait-relevant polygenic scores

Advancing long-read nanopore genome assembly and accurate variant calling for rare disease detection

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Joint, multifaceted genomic analysis enables diagnosis of diverse, ultra-rare monogenic presentations

Structural variant calling and clinical interpretation in 6224 unsolved rare disease exomes

Long-read genome sequencing and variant reanalysis increase diagnostic yield in neurodevelopmental disorders

The functional impact of rare variation across the regulatory cascade

Clinical application of Complete Long Read genome sequencing identifies a 16kb intragenic duplication in EHMT1 in a patient with suspected Kleefstra syndrome

Nanopore sequencing of 1000 Genomes Project samples to build a comprehensive catalog of human genetic variation

Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases

Mapping and characterization of structural variation in 17,795 deeply sequenced human genomes

Pangenome graphs improve the analysis of structural variants in rare genetic diseases

Unravelling undiagnosed rare disease cases by HiFi long-read genome sequencing

Long-read sequencing of hundreds of diverse brains provides insight into the impact of structural variation on gene expression and DNA methylation

High-coverage nanopore sequencing of samples from the 1000 Genomes Project to build a comprehensive catalog of human genetic variation

Full characterization of unresolved structural variation through long-read sequencing and optical genome mapping

Long-read sequencing and structural variant characterization in 1,019 samples from the 1000 Genomes Project

Uncovering recessive alleles in rare Mendelian disorders by genome sequencing of 174 individuals with monoallelic pathogenic variants

Identification of synonymous pathogenic variants in monogenic disorders by integrating exome with transcriptome sequencing